BeyondSpring Pharmaceuticals Inc.
Nasdaq BYSI · Florham Park, NJ
Works in Oncology · Respiratory
BeyondSpring Pharmaceuticals Inc. is a clinical trial sponsor based in Florham Park, NJ, listed as Nasdaq BYSI. It has 1 active clinical trial with 442 planned participants, in Oncology and Respiratory. Since 2021 it has completed 3 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq BYSI
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about BeyondSpring Pharmaceuticals Inc
BeyondSpring Pharmaceuticals Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 442 planned participants, in Oncology, Respiratory. Since 2021 it has completed 3 trials and stopped 0 early.
BeyondSpring Pharmaceuticals Inc is based in Florham Park, NJ and is listed as Nasdaq BYSI. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with BeyondSpring Pharmaceuticals Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-29.
Approve Suite is not affiliated with BeyondSpring Pharmaceuticals Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.